Prenatal Testing for Fragile X Syndrome: CVS and Amniocentesis
Fragile X syndrome can be diagnosed prenatally via:
- Chorionic Villus Sampling (CVS): 10–13 weeks; placental biopsy. Miscarriage risk <1%.
- Amniocentesis: 15–20 weeks; amniotic fluid culture. Miscarriage risk <1%.
Testing targets the FMR1 CGG repeat expansion. Indicated for known carriers, family history, or abnormal prenatal screening. Genetic counseling is essential before and after testing to discuss implications and reproductive options.
Genetic Disorders - Related Articles
- Understanding Genograms & Pedigrees: Ethical Considerations in Genetic Mapping
- Marfan Syndrome: Facial & Spinal Characteristics - What to Look For
- Effects of Faulty Genes on Human Health: From Traits to Disease
- Understanding Genetic Diseases: Causes, Inheritance & Autism
- Down Syndrome Is a Chromosomal Disorder, Not a Frameshift Mutation
- Precocious Puberty: Understanding Causes, Symptoms & Prevalence
- Understanding Syndrome Causes: Genetic, Environmental & Immune Factors
